Latest Articles
DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer | AZN Stock News - GuruFocus
DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer | AZN Stock News GuruFocus
Published: June 9, 2025, 12:18 p.m.
Woman, 22, Forced to Freeze Eggs After Stage 4 Endometriosis Diagnosis: 'I Don't Even Know If I Want Kids' (Exclusive) - MSN
Woman, 22, Forced to Freeze Eggs After Stage 4 Endometriosis Diagnosis: 'I Don't Even Know If I Want Kids' (Exclusive) MSN
Published: June 9, 2025, 8:01 a.m.
Obesity-induced inflammation plays a crucial role in endometrial cancer... - researchgate.net
Obesity-induced inflammation plays a crucial role in endometrial cancer... researchgate.net
Published: June 9, 2025, 1:53 a.m.
Woman, 22, Forced to Freeze Eggs After Stage 4 Endometriosis Diagnosis: 'I Don't Even Know If I Want Kids' (Exclusive) - AOL.com
Woman, 22, Forced to Freeze Eggs After Stage 4 Endometriosis Diagnosis: 'I Don't Even Know If I Want Kids' (Exclusive) AOL.com
Published: June 8, 2025, 6:38 p.m.
Woman, 22, Forced to Freeze Eggs After Stage 4 Endometriosis Diagnosis: 'I Don't Even Know If I Want Kids' (Exclusive) - People.com
Woman, 22, Forced to Freeze Eggs After Stage 4 Endometriosis Diagnosis: 'I Don't Even Know If I Want Kids' (Exclusive) People.com
Published: June 6, 2025, 6:49 p.m.
Fluorescence-guided ureteral identification in robotic surgery for advanced endometriosis: a comparison of junior versus senior surgeons - Nature
Fluorescence-guided ureteral identification in robotic surgery for advanced endometriosis: a comparison of junior versus senior surgeons Nature
Published: June 6, 2025, 9:12 a.m.
Genmab progresses with reduced dose of Rina-S in endometrial cancer studies - MSN
Genmab progresses with reduced dose of Rina-S in endometrial cancer studies MSN
Published: June 6, 2025, 12:53 a.m.
Doctors advocate for pain transparency in gynaecological procedures - Cayman Compass
Doctors advocate for pain transparency in gynaecological procedures Cayman Compass
Published: June 4, 2025, 4:58 a.m.
Genmab A/S (GMAB) Reports 50% Response Rate With Rina-S in Advanced Endometrial Cancer - Insider Monkey
Genmab A/S (GMAB) Reports 50% Response Rate With Rina-S in Advanced Endometrial Cancer Insider Monkey
Published: June 3, 2025, 5 a.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - BioSpace
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial BioSpace
Published: June 2, 2025, 11:48 p.m.
Link copied to clipboard!